Early recombinant activated factor VII for intracerebral hemorrhage reduced hematoma growth and mortality, while improving functional outcomes.
Emlet
Lillian L
LL
Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Crippen
David
D
D002543:Cerebral Hemorrhage / Q000188:drug therapy* / Q000401:mortality*; D015942:Factor VIIa / Q000627:therapeutic use*; D006406:Hematoma / Q000188:drug therapy / Q000401:mortality; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000401:mortality*; D016896:Treatment Outcome
D015942:Factor VIIa